Publicaciones en las que colabora con Jesús Egido de los Ríos (23)

2021

  1. Bisphenol S is a haemodialysis-associated xenobiotic that is less toxic than bisphenol A

    Clinical Kidney Journal, Vol. 14, Núm. 4, pp. 1147-1155

2018

  1. Targeting inflammation in diabetic nephropathy: a tale of hope

    Expert Opinion on Investigational Drugs, Vol. 27, Núm. 11, pp. 917-930

2017

  1. Bisfenol (A) una toxina a tener en cuenta en el enfermo renal en hemodiálisis

    Revista Colombiana de Nefrología, Vol. 4, Núm. 1, pp. 57-68

  2. Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway

    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 10, pp. 207-222

2011

  1. Animal models of cardiovascular diseases

    Journal of Biomedicine and Biotechnology, Vol. 2011

  2. Proteomic approach to the study of statin pleiotropy in kidney transplant patients

    Pharmacology, Vol. 87, Núm. 3-4, pp. 161-168

2008

  1. Cluster TOF-SIMS imaging: A new light for in situ metabolomics?

    Proteomics, Vol. 8, Núm. 18, pp. 3735-3745

  2. Proteomics in atherosclerosis

    Current Atherosclerosis Reports, Vol. 10, Núm. 3, pp. 209-215

2007

  1. Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques

    European Journal of Pharmacology, Vol. 562, Núm. 1-2, pp. 119-129

  2. Lipid cartography of atherosclerotic plaque by cluster-TOF-SIMS imaging

    Analyst, Vol. 132, Núm. 1, pp. 24-26

2005

  1. Quest for novel cardiovascular biomarkers by proteomic analysis

    Journal of Proteome Research, Vol. 4, Núm. 4, pp. 1181-1191